We are live on ! Find out more
ABVX icon

Abivax

258 hedge funds and large institutions have $5.53B invested in Abivax in 2026 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 114 increasing their positions, 75 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more call options, than puts

Call options by funds: $233M | Put options by funds: $142M

52% more repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 75

23% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 44

3% more funds holding

Funds holding: 250 → 258 (+8)

9.04% less ownership

Funds ownership: 72.26% → 63.22% (-9%)

18% less funds holding in top 10

Funds holding in top 10: 34 → 28 (-6)

55% less capital inflows, than outflows

Capital inflows: $647M | Capital outflows: $1.43B

Holders
258
Holders Change
+8
Holders Change %
+3.2%
% of All Funds
3.13%
Holding in Top 10
28
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-17.65%
% of All Funds
0.34%
New
54
Increased
114
Reduced
75
Closed
44
Calls
$233​M
Puts
$142​M
Net Calls
+$90.2​M
Net Calls Change
-⁠$23​M

ABVX Hedge Fund Activity: Q1 2026 in Review

258 of the 8,243 institutional investors tracked by Wall St. Rank reported a position in Abivax (ABVX) for Q1 2026, worth a combined $5.53B — down 27% from $7.61B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new ABVX positions and 44 closed out — a net gain of 10 holders — while 114 added to existing stakes and 75 trimmed.

The largest buyer was Helikon Investments, opening a new position worth an estimated $120M. The largest seller was Point72 Asset Management, cutting an estimated $210M.

  • 258 institutional investors held Abivax (ABVX) as of Q1 2026, up from 250 in Q4 2025.
  • Funds reported $5.53B of Abivax stock for Q1 2026, down 27% quarter-over-quarter.
  • 54 funds opened new Abivax positions in Q1 2026 and 44 closed out, a net change of +10 holders.
  • The largest Abivax buyer in Q1 2026 was Helikon Investments, an estimated $120M added.
  • The largest Abivax seller in Q1 2026 was Point72 Asset Management, an estimated $210M sold.

Based on aggregated 13F filings for Q1 2026.